AHFS February 2026 Update

This update contains 6 new monographs and 38 revised monographs.

New monographs: Indapamide; Onasemnogene Abeparvovec-brve;
Plozasiran Sodium; Sevabertinib; Sibeprenlimab-szsi; Ziftomenib.

Revised monographs: AHFS Drug Information® Users Guide; Anacaulase-
bcdb; Atidarsagene Autotemcel; Brexucabtagene Autoleucel; Captopril;
Copyright and Notices; Dolasetron Mesylate; Donislecel-jujn; Editorial
Staff; Fingolimod Hydrochloride; Fluorouracil (Systemic); Ganaxolone;
Inavolisib; Isradipine; Lebrikizumab-lbkz; Lenacapavir Sodium; Leniolisib
Phosphate; Lithium; Meningococcal Group B Vaccine; Meningococcal
Groups A, C, Y, and W-135 Vaccine; Nadofaragene Firadenovec-vncg;
NIFEdipine; Nisoldipine; Ofatumumab; Onasemnogene Abeparvovec-xioi;
Pancuronium Bromide; Penpulimab-kcqx; Perfluorohexyloctane; Preface;
Rilzabrutinib; Selenious Acid; Sparsentan; Sunvozertinib; Taurolidine and
Heparin Sodium; Teclistamab-cqyv; Tislelizumab-jsgr; Verapamil
Hydrochloride; Zavegepant Hydrochloride.